SOPHiA GENETICS (SOPH) Operating Income (2020 - 2025)

SOPHiA GENETICS has disclosed Operating Income across 6 years of filings, most recently posting -$18.5 million for Q4 2025.

• Operating Income for Q4 2025 came in at -$18.5 million, down 6.15% year-over-year; the trailing twelve-month figure through Dec 2025 was -$70.9 million (down 6.52% YoY), and the FY2025 annual result was -$70.9 million, down 6.52% from the prior year.
• Operating Income came in at -$18.5 million for Q4 2025 at SOPHiA GENETICS, down from -$17.9 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$14.1 million in Q1 2021 to a low of -$20502.0 billion in Q3 2021.
• The 5-year median for Operating Income is -$18.5 million (2025), against an average of -$1025.1 billion.
• Across the five-year window, Operating Income sank 217389460190.53% in 2021 and jumped 100.0% in 2022, its largest moves.
• SOPHiA GENETICS's Operating Income stood at -$21.0 million in 2021, then rose by 28.21% to -$15.1 million in 2022, then retreated by 25.61% to -$18.9 million in 2023, then advanced by 7.93% to -$17.4 million in 2024, then decreased by 6.15% to -$18.5 million in 2025.
• The last three Operating Income figures came in at -$18.5 million (Q4 2025), -$17.9 million (Q3 2025), and -$18.5 million (Q2 2025), per Business Quant data.